Related Experiment Videos

Mesangiocapillary glomerulonephritis: changes in glomerular morphology with long-term alternate-day prednisone

Insights

Prednisone treatment in mesangiocapillary glomerulonephritis patients improved glomerular morphology and function. While some deposits and scarring persisted, renal function remained stable over long-term follow-up.

Area of Science:

  • Nephrology
  • Immunopathology
  • Glomerular Diseases

Background:

  • Mesangiocapillary glomerulonephritis (MCG) is a severe kidney disease characterized by mesangial cell proliferation and immune deposits.
  • Current treatment options for MCG have limited efficacy and can lead to progressive renal damage.

Purpose of the Study:

  • To evaluate the long-term effects of alternate-day prednisone therapy on kidney morphology and function in patients with mesangiocapillary glomerulonephritis.

Main Methods:

  • Eight patients with MCG received prednisone on an alternate-day schedule.
  • Kidney biopsies were analyzed for changes in mesangial cellularity, interposition, and deposits.
  • Renal function was monitored over a follow-up period of 5 to 11.5 years.

Main Results:

  • Prednisone treatment led to significant reduction in mesangial cellularity and regression of mesangial interposition.
  • Subendothelial deposits resolved, but intramembranous deposits persisted in some patients.
  • Despite incomplete histological repair, functional glomeruli showed improved morphology, and renal function remained stable without deterioration.

Conclusions:

  • Alternate-day prednisone therapy can induce significant histological improvements in mesangiocapillary glomerulonephritis.
  • The treatment appears to halt disease progression and preserve renal function in the long term.
  • Further research is warranted to optimize prednisone regimens and assess combination therapies for MCG.

Related Concept Videos